Michael Scolaro

Michael Scolaro

Aug 29, 2017

Group 6 Copy 203
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Antibiotics and Affect: Avenues for Addiction Management

    Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

    Community-based Leishmaniasis research in Sri Lanka

    Leishmaniasisis a neglected tropical parasitic diseases in the world and is spread by the bite of sand flies...

    Can anle138b delay the onset of genetic prion disease?

    Prions - infectious proteins - cause fatal, untreatable neurodegenerative diseases. A promising new compound...

    Backer Badge Funded